1. Home
  2. PRTA vs CTBI Comparison

PRTA vs CTBI Comparison

Compare PRTA & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • CTBI
  • Stock Information
  • Founded
  • PRTA 2012
  • CTBI 1903
  • Country
  • PRTA Ireland
  • CTBI United States
  • Employees
  • PRTA N/A
  • CTBI N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • CTBI Major Banks
  • Sector
  • PRTA Health Care
  • CTBI Finance
  • Exchange
  • PRTA Nasdaq
  • CTBI Nasdaq
  • Market Cap
  • PRTA 809.8M
  • CTBI 922.9M
  • IPO Year
  • PRTA N/A
  • CTBI N/A
  • Fundamental
  • Price
  • PRTA $9.20
  • CTBI $47.19
  • Analyst Decision
  • PRTA Buy
  • CTBI Buy
  • Analyst Count
  • PRTA 9
  • CTBI 2
  • Target Price
  • PRTA $54.57
  • CTBI $57.00
  • AVG Volume (30 Days)
  • PRTA 557.1K
  • CTBI 71.8K
  • Earning Date
  • PRTA 05-07-2025
  • CTBI 04-16-2025
  • Dividend Yield
  • PRTA N/A
  • CTBI 3.93%
  • EPS Growth
  • PRTA N/A
  • CTBI 10.88
  • EPS
  • PRTA N/A
  • CTBI 4.79
  • Revenue
  • PRTA $135,157,000.00
  • CTBI $244,136,000.00
  • Revenue This Year
  • PRTA N/A
  • CTBI $14.93
  • Revenue Next Year
  • PRTA $131.71
  • CTBI $4.07
  • P/E Ratio
  • PRTA N/A
  • CTBI $9.93
  • Revenue Growth
  • PRTA 47.92
  • CTBI 10.52
  • 52 Week Low
  • PRTA $9.10
  • CTBI $39.48
  • 52 Week High
  • PRTA $25.42
  • CTBI $61.67
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 26.58
  • CTBI 40.08
  • Support Level
  • PRTA $9.30
  • CTBI $44.60
  • Resistance Level
  • PRTA $10.45
  • CTBI $47.74
  • Average True Range (ATR)
  • PRTA 0.81
  • CTBI 2.03
  • MACD
  • PRTA -0.15
  • CTBI 0.02
  • Stochastic Oscillator
  • PRTA 2.77
  • CTBI 40.28

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

Share on Social Networks: